1. 2024
  2. Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing

    Alrhmoun, S., Fisher, M., Lopatnikova, J., Perik-Zavodskaia, O., Volynets, M., Perik-Zavodskii, R., Shevchenko, J., Nazarov, K., Philippova, J., Alsalloum, A., Kurilin, V., Silkov, A. & Sennikov, S., Dec 2024, In: Cancers. 16, 23, 4020.

    Research output: Contribution to journalArticlepeer-review

  3. Acute blood loss in mice forces differentiation of both CD45-positive and CD45-negative erythroid cells and leads to a decreased CCL3 chemokine production by bone marrow erythroid cells

    Nazarov, K., Perik-Zavodskii, R., Perik-Zavodskaia, O., Alrhmoun, S., Volynets, M., Shevchenko, J. & Sennikov, S., Sept 2024, In: PLoS ONE. 19, 9, 18 p., e0309455.

    Research output: Contribution to journalArticlepeer-review

  4. NY-ESO-1 antigen: A promising frontier in cancer immunotherapy.

    Alsalloum, A., Shevchenko, J. A. & Sennikov, S., Sept 2024, In: Clinical and translational medicine. 14, 9, p. e70020

    Research output: Contribution to journalReview articlepeer-review

  5. A subpopulation of human bone marrow erythroid cells displays a myeloid gene expression signature similar to that of classic monocytes

    Perik-Zavodskii, R., Perik-Zavodskaia, O., Shevchenko, J., Volynets, M., Alrhmoun, S., Nazarov, K., Denisova, V. & Sennikov, S., Jul 2024, In: PLoS ONE. 19, 7 July, p. e0305816 e0305816.

    Research output: Contribution to journalArticlepeer-review

  6. Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in a melanoma murine xenograft model

    Alsalloum, A., Alrhmoun, S., Perik-Zavosdkaia, O., Fisher, M., Volynets, M., Lopatnikova, J., Perik-Zavodskii, R., Shevchenko, J., Philippova, J., Solovieva, O., Zavjalov, E., Kurilin, V., Shiku, H., Silkov, A. & Sennikov, S., 2024, In: Frontiers in Immunology. 15, 11 p., 1507218.

    Research output: Contribution to journalArticlepeer-review

  7. 2023
  8. Phenotypic Alterations in Erythroid Nucleated Cells of Spleen and Bone Marrow in Acute Hypoxia

    Nazarov, K., Perik-Zavodskii, R., Perik-Zavodskaia, O., Alrhmoun, S., Volynets, M., Shevchenko, J. & Sennikov, S., Dec 2023, In: Cells. 12, 24, 2810.

    Research output: Contribution to journalArticlepeer-review

  9. TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors

    Alsalloum, A., Alrhmoun, S., Shevchenko, J., Fisher, M., Philippova, J., Perik-Zavodskii, R., Perik-Zavodskaia, O., Lopatnikova, J., Kurilin, V., Volynets, M., Akahori, Y., Shiku, H., Silkov, A. & Sennikov, S., 16 Oct 2023, In: Biomedicines. 11, 10, 2805.

    Research output: Contribution to journalArticlepeer-review

  10. Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4

    Alsalloum, A., Shevchenko, J., Fisher, M., Philippova, J., Perik-Zavodskii, R., Perik-Zavodskaia, O., Alrhmoun, S., Lopatnikova, J., Vasily, K., Volynets, M., Zavjalov, E., Solovjeva, O., Akahori, Y., Shiku, H., Silkov, A. & Sennikov, S., 13 Oct 2023, In: International Journal of Molecular Sciences. 24, 20, 15134.

    Research output: Contribution to journalArticlepeer-review

  11. Parameters of TNF receptor co-expression in allergic and autoimmune processes: Differences and diagnostic significance

    Alshevskaya, A., Zhukova, J., Lopatnikova, J., Shkaruba, N., Chumasova, O., Sizikov, A., Demina, D., Nepomniashchikh, V., Gladkikh, V. & Sennikov, S., Sept 2023, In: Journal of immunological methods. 520, 7 p., 113525.

    Research output: Contribution to journalArticlepeer-review

  12. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?

    Alsalloum, A., Shevchenko, J. A. & Sennikov, S., 15 Mar 2023, In: Cancers. 15, 6, 1779.

    Research output: Contribution to journalReview articlepeer-review

  13. Development of experimental mouse xenograft models of human tumors for preclinical in vivo studies of product for cellular immunotherapy

    Lopatnikova, J. A., Shevchenko, J. A., Filippova, J. G., Fisher, M. S., Obleukhova, I. A., Zavjalov, E. L., Solovjeva, O. I., Razumov, I. A., Akahori, Y., Shiku, H. & Sennikov, S. V., 2023, In: Immunologiya. 44, 6, p. 709-720 12 p.

    Research output: Contribution to journalArticlepeer-review

  14. Investigation of TNF receptor coexpression parameters as potential biomarkers of effective hospital therapy with rituximab in patients with rheumatoid arthritis

    Alshevskaya, A. A., Lopatnikova, J. A., Zhukova, J. V., Kireev, F. D., Gladkikh, V. S., Shkaruba, N. S., Chumasova, O. A., Sizikov, A. E. & Sennikov, S. V., 2023, In: Immunologiya. 44, 4, p. 429-443 15 p.

    Research output: Contribution to journalArticlepeer-review

  15. 2022
  16. The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions

    Alrhmoun, S. & Sennikov, S., 14 Dec 2022, In: Cancers. 14, 24, 6173.

    Research output: Contribution to journalReview articlepeer-review

  17. In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes

    Shevchenko, J. A., Lopatnikova, J. A., Khantakova, J. N., Silkov, A. N., Kuznetsova, M. S., Kurilin, V. V., Maksyutov, A. Z. & Sennikov, S. V., Jun 2022, In: Frontiers in Bioscience - Landmark. 27, 6, 170.

    Research output: Contribution to journalArticlepeer-review

  18. Современная терапия рака молочной железы: от тамоксифена до т-клеточной инженерии

    Shevchenko, J. A., Kuznetsova, M. S., Khristin, A. A., Sidorov, S. V. & Sennikov, S. V., 2022, In: Siberian Journal of Oncology. 21, 5, p. 109-122 14 p., 12.

    Research output: Contribution to journalArticlepeer-review

  19. 2021
  20. Ligand-regulated expression of TNF receptors 1 and 2 determines receptor-mediated functional responses

    Alshevskaya, A., Koneva, O., Belomestnova, I., Lopatnikova, J., Evsegneeva, I., Zhukova, J., Kireev, F., Karaulov, A. & Sennikov, S., 1 Nov 2021, In: International Archives of Allergy and Immunology. 182, 11, p. 1077-1088 12 p.

    Research output: Contribution to journalArticlepeer-review

  21. Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment

    Alshevskaya, A., Lopatnikova, J., Zhukova, J., Chumasova, O., Shkaruba, N., Sizikov, A. & Sennikov, S., Aug 2021, In: European Journal of Immunology. 51, p. 232-232 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  22. Number and co-expression of TNF receptors type 1 and 2 on immunocompetent cells are associated with stability of remission in rheumatoid arthritis patients

    Alshevskaya, A., Lopatnikova, J., Zhukova, J., Chumasova, O., Shkaruba, N., Sizikov, A. & Sennikov, S., Jun 2021, In: Annals of the rheumatic diseases. 80, Suppl 1, p. 482-483 3 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  23. The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivo

    Tereshchenko, V., Bulygin, A., Zavodskii, R., Maksyutov, A., Kurilin, V., Fisher, M., Semenyuk, N., Aladev, S. & Sennikov, S., Jun 2021, In: Cytokine. 142, 155473.

    Research output: Contribution to journalArticlepeer-review

  24. Особенности количественной экспрессии рецепторов checkpoint-молекул PD-1 и TIM-3 на CD4+ и CD8+Т-клетках при раке молочной железы разной степени прогрессии

    Shevchenko, Y. A., Kuznetsova, M. S., Khantakova, Y. N., Obleukhova, I. A., Khristin, A. A., Sidorov, S. V. & Sennikov, S. V., 2021, In: Medical Immunology (Russia). 23, 4, p. 865-870 6 p., 38.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 Next

ID: 16345732